Optometrists in Quincy, WA Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Christopher Glen Petersen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 701 2nd Ave Se, Quincy, WA 98848 Phone: 509-787-1581 Fax: 509-787-9176 |
Kyle Morgan Gillespie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 701 2nd Ave Se, Quincy, WA 98848 Phone: 509-787-1581 |
 Gillespie Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 701 2nd Ave Se, Quincy, WA 98848 Phone: 509-787-1581 Fax: 509-787-9176 |
News Archive
Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients
C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke. Studies have report a higher C677T homozygosity frequency in Chinese than in Europeans. Usually, the detection of genetic diseases is rather complicated on a large scale owing to the invasive sampling and a cumbersome DNA extraction process.
Astute Medical hails launch of collaborative global initiative to prevent deaths from AKI by 2025
Astute Medical, Inc. today hailed the launch of a collaborative global initiative calling for the elimination of preventable deaths from acute kidney injury (AKI) by 2025. The Company cited the publication of a new Commission from The Lancet and the International Society of Nephrology, along with the release of results from the 0by25 AKI "Global Snapshot" study, as key steps forward in the effort to reduce the global burden of AKI.
Scientists are collecting big data to expedite the fight against COVID-19
A nationwide collaboration of clinicians, informaticians and other biomedical researchers aims to turn data from hundreds of thousands of medical records from coronavirus patients into effective treatments and predictive analytical tools that could help lessen or end the global pandemic.
Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease
Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease, a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure, and likely other liver diseases.
SMFM praises FDA's announcement on Makena drug
The Society for Maternal-Fetal Medicine weighed in on today's FDA announcement to continue to allow pharmacies to compound hydroxyprogesterone caproate, also known as 17P.
› Verified 3 days ago
Chiropractors
Physical Therapists
Speech-Language Pathologists
Optometrists